Canopy Growth Corporation (CGC) vs Emergent Biosolutions Inc. (EBS)
- Canopy Growth Corporation CGC 0.71 −4.05%
- Emergent Biosolutions Inc. EBS 6.38 −11.14%
Canopy Growth Corporation and Emergent Biosolutions Inc. are both Drug Manufacturers Specialty & Generic companies. Emergent Biosolutions Inc. is the larger, with a market value of $368.1M against $311.2M — 1.2× the size. Canopy Growth Corporation grew revenue faster over the last twelve months: 7.80% against −9.56%. Emergent Biosolutions Inc. has the higher net margin (−23.0% vs −80.4%) and the higher return on invested capital (−5.27% vs −17.2%). Across the 19 metrics below, Emergent Biosolutions Inc. leads on 12 and Canopy Growth Corporation on 7.
Valuation
Profitability
| Metric | CGC | EBS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 25.16% | 55.87% | 53.94% |
| Operating margin | (54.89%) | (8.57%) | 0.00% |
| Net margin | (80.39%) | (22.96%) | 0.00% |
| Free cash flow margin | (28.34%) | 11.18% | 0.00% |
| Return on equity | (40.14%) | (40.29%) | (0.40%) |
| Return on assets | (23.54%) | (13.95%) | (3.32%) |
| Return on invested capital | (17.19%) | (5.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack